The purpose of the Administrative Core is (1) to provide overall direction and provide fiscal management for the Indiana Alzheimer Disease Center (IADC), (2) to coordinate and integrate the activities of the IADC components, (3) to encourage research into Alzheimer disease (AD) and related disorders by the faculty at Indiana University School of Medicine and (4) to encourage, evaluate, support and supervise the conduct of the pilot project. The Core Leader is Dr. Bernardino Ghetti. He will be assisted by an Associate Co-Director Dr. Martin R. Farlow. One of the IADC missions is that of nurturing new research in AD and related dementias and of encouraging new investigators to develop research interests in areas of AD. Two pilot projects will be available annually through the IADC. Junior investigators from Indiana University are encouraged to apply. A call for research proposals will be made annually to all chairpersons and directors of centers, institutes and divisions within Indiana University and Purdue University as well as other selected institutions that do not have an Alzheimer disease center.

Public Health Relevance

It is estimated that as many as 5 million Americans have AD. The Indiana Alzheimer Disease Center provides an environment and resources directed towards fostering and coordinating research and educational activities on AD and other dementing illnesses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010133-22
Application #
8382723
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2012-07-15
Budget End
2013-06-30
Support Year
22
Fiscal Year
2012
Total Cost
$279,706
Indirect Cost
$98,079
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Campbell, Noll L; Lane, Kathleen A; Gao, Sujuan et al. (2018) Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care. Pharmacotherapy 38:511-519
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Yan, Jingwen; Liu, Kefei; Li, Huang et al. (2018) JOINT EXPLORATION AND MINING OF MEMORY-RELEVANT BRAIN ANATOMIC AND CONNECTOMIC PATTERNS VIA A THREE-WAY ASSOCIATION MODEL. Proc IEEE Int Symp Biomed Imaging 2018:6-9
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Murray, Michael D; Hendrie, Hugh C; Lane, Kathleen A et al. (2018) Antihypertensive Medication and Dementia Risk in Older Adult African Americans with Hypertension: A Prospective Cohort Study. J Gen Intern Med 33:455-462
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10

Showing the most recent 10 out of 604 publications